Wikidata

(Q61637057)

English

Angiogenesis Inhibitor IM862 Is Ineffective Against AIDS-Kaposi's Sarcoma in a Phase III Trial, but Demonstrates Sustained, Potent Effect of Highly Active Antiretroviral Therapy: From the AIDS Malignancy Consortium and IM862 Study Team

article

In more languages

Statements

title
Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15598977
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15598977%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 January 2020

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61637057&oldid=1779100978"